- Journal of Health Sciences and Medicine
- Volume:5 Issue:6
- Neurologic symptoms and signs observed in critical COVID-19 patients may be precursors of existing c...
Neurologic symptoms and signs observed in critical COVID-19 patients may be precursors of existing cerebrovascular disease
Authors : Ayşe YILMAZ, Veysel Garani SOYLU, Ufuk DEMİR, Öztürk TAŞKIN, Zahide DOĞANAY
Pages : 1644-1649
Doi:10.32322/jhsm.1180623
View : 16 | Download : 7
Publication Date : 2022-10-25
Article Type : Research Paper
Abstract :Introduction: Although COVID-19 disease often includes respiratory system findings, that affects the gastrointestinal system, circulatory system, coagulation system and neurological system. In this study, we identified the neurological signs and symptoms observed in critical COVID-19 patients. Material and Method: This retrospective study reviewed 595 COVID-19 patients admitted to our intensive care unit insert ignore into journalissuearticles values(ICU); between January to June 2020. Patients with neurologic symptoms that were divided into two groups were diagnosed neurological disease insert ignore into journalissuearticles values(group ND); and non-neurological disease insert ignore into journalissuearticles values(group non-ND);. Clinical signs and symptoms, radiological findings, demographic data insert ignore into journalissuearticles values(age, gender, presence of comorbidities);, white blood cell insert ignore into journalissuearticles values(WBC);, lymphocyte, platelet, lactic acid, glucose, and D-dimer levels, length of hospitalization, requirement of mechanical ventilation, and mortality were recorded for each patient. Results: Neurologic symptoms were observed in 148 insert ignore into journalissuearticles values(24.8%); patients. Of these, 44 patients were diagnosed neurological disease and 104 patients were non- neurological disease. The prevalence of neurologic symptoms was significantly higher in group ND. The rate of acute ischemic cerebrovascular disease in 595 critical COVID-19 patients was 6.2%. Conclusion: Presence of cerebrovascular diseases should be suspected in COVID-19patients with paresis, altered consciousness, numbness, taste/smell disorders, and plegia. The rate of ischemic cerebrovascular disease was approximately seven times higher than the rate of hemorrhagic cerebrovascular disease in critically COVID-19 patients.Keywords : Intensive care unit, neurology, COVID 19, acute ischemic stroke